Ozempic belly injection tutorial: what TikTok gets right and wrong

What did @patymarquesolii actually say?

Honestly? Not much that's usable. The transcript is largely incoherent, with repeated phrases like "I will show you how to do it" and references to undefined terms like "gondos" that appear to be transcription artifacts from Portuguese-language audio run through a poor auto-translator. The video claims to demonstrate Ozempic abdominal injection technique, but the actual spoken content doesn't deliver coherent medical instruction. The caption says "how I do the Ozempic application on my belly," which is the only concrete claim we can actually evaluate.

This is a common pattern in Brazilian-Portuguese health content on TikTok: the caption and hashtags carry the real message, while the spoken content is either auto-dubbed or poorly transcribed. The creator isn't pretending to be a medical professional, which at least sets honest expectations. But 66,600 viewers watched this for injection guidance, and that's worth taking seriously regardless of the creator's intent.

Does the science back the general premise?

Self-administration of subcutaneous semaglutide injections in the abdomen is legitimate and FDA-label consistent. The abdominal site is one of three approved injection locations for semaglutide, alongside the thigh and upper arm. That part isn't controversial. What matters is technique, and technique is where casual TikTok tutorials tend to fall apart.

A 2022 review by Blonde et al. in Diabetes, Obesity and Metabolism confirmed that patient-administered subcutaneous GLP-1 injections are generally safe when proper technique is used, but errors in injection depth, site rotation, and needle handling are common in unsupervised self-injection settings. The pen device for Ozempic (semaglutide 0.25-2mg) is designed to reduce technique errors, but it doesn't eliminate them. Injecting into scar tissue, injecting intramuscularly by accident, or reusing needles are documented real-world problems. A 15-second TikTok demo doesn't adequately address any of those risks.

What did they get wrong, or right?

We genuinely cannot evaluate the visual demonstration because we only have the transcript. But based on what the creator communicated verbally, there's essentially nothing to fact-check. No dosing claims were made. No disease-cure claims were made. No comparison to compounded semaglutide was made. That's the floor of responsible content, and they cleared it, even if they cleared it by saying almost nothing medically substantive.

What's worth flagging is the hashtag "perderpesofacil" which translates to "easy weight loss." That framing is misleading regardless of what the video shows. Semaglutide produces meaningful weight loss in clinical trials, with Wilding et al. (2021, NEJM) showing 14.9% body weight reduction on average over 68 weeks, but that's not easy. It involves side effects, dietary adjustment, and consistent medical supervision. Calling any GLP-1 regimen "easy weight loss" does a disservice to people who will hit nausea, vomiting, and plateau phases and think they're doing something wrong.

What should you actually know about self-injecting semaglutide?

Abdominal injection is valid. The technique actually matters more than most people assume. The abdomen should be used in a rotation pattern, not the same spot every week, because repeated injections in one location can cause lipohypertrophy, a fatty tissue buildup that impairs drug absorption. That's not a rare edge case. It's documented in insulin-dependent diabetics and applies equally to GLP-1 pens.

• Pinch the skin to create a subcutaneous fold before injecting. Ozempic is not an intramuscular injection.
• Rotate sites within the abdomen, keeping injections at least 2cm from the navel and away from scars or bruised skin.
• Never reuse needles. The needle tip degrades after one use, increasing pain and infection risk.
• Store unused pens at 2-8 degrees Celsius. After first use, pens can be kept at room temperature below 30 degrees Celsius for up to 56 days.
• If you see blood after removing the needle, apply light pressure. Do not rub the site, which can disperse the medication unevenly.

None of this requires a medical degree to follow, but it does require actual instruction. A video that demonstrates without explaining, or explains without the viewer being able to understand the language, leaves a real gap.

The bigger picture on DIY GLP-1 content

TikTok has become a primary education channel for people using semaglutide outside formal endocrinology or obesity medicine settings. A 2023 analysis by Blenner et al. in JAMA found that the majority of weight-loss drug content on social platforms omits side effect information and lacks any reference to professional supervision. This video fits that pattern. The creator isn't malicious, and the content isn't dangerous in any specific, identifiable way. But the combination of high view counts, low information density, and a hashtag framing GLP-1 therapy as easy creates a misleading overall impression that patients deserve better than.